Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $383,922.54 mil
Piotroski score: 4
PE Ratio: 107.5289
EPS (TTM): 2.0489
Revenue (TTM): $35.41 M
Dividend Yield: 3.196452492032%
ROE: 95.59%
Latest News
-
How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story
Fri, Jun 19, 2026 12:56 AM
-
FDA Seeks Updated Labeling for Testosterone Therapies
Thu, Jun 18, 2026 9:56 PM
-
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Thu, Jun 18, 2026 9:45 PM
-
What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine?
Thu, Jun 18, 2026 8:57 PM
-
AbbVie Declares Quarterly Dividend
Thu, Jun 18, 2026 8:05 PM
-
Portal Biotechnologies Accelerates Growth with Latest Round Led by NFX, Expanded DARPA Contract, and Broad Adoption Across Top Pharma and Academic Centers
Thu, Jun 18, 2026 11:30 AM
-
AbbVie (ABBV) Lands New SKINVIVE Approval As CLL Trial Results Impress
Thu, Jun 18, 2026 11:13 AM
-
Abivax: Safety Signals Loom Ahead Of The NDA Submission
Thu, Jun 18, 2026 6:53 AM
-
Eli Lilly Stock's Trillion-Dollar Question
Wed, Jun 17, 2026 6:21 PM
-
AbbVie Inc. (ABBV) Presents Data on Fixed-Duration Venetoclax-Based Combination
Wed, Jun 17, 2026 5:34 PM
Key Financials
Financial data not available
